Literature DB >> 8682585

Prognostic value of E-cadherin expression in 413 gastric carcinomas.

H E Gabbert1, W Mueller, A Schneiders, S Meier, R Moll, W Birchmeier, G Hommel.   

Abstract

E-cadherin is a Ca(2+)-dependent intercellular adhesion molecule known to exert an invasion-suppressor function. In the present study, E-cadherin expression was immunohistochemically investigated in a retrospective series of 413 RO-resected gastric carcinomas using the monoclonal antibody (MAb) 5H9. Of these cases, 108 tumors revealed a preserved E-cadherin expression similar to that of normal gastric mucosa. In 95 tumors, E-cadherin expression was moderately reduced and in 86 tumors highly reduced. In 124 tumors, no or only a very weak dotted expression could be detected. There was a significant correlation between the degree of E-cadherin expression and the grade of tumor differentiation, as well as with histological type according to the Laurén and the WHO classifications. In contrast, no correlation could be demonstrated between E-cadherin expression and the prognostic parameters depth of invasion, lymph node involvement and vascular invasion. As shown by univariate Cox regression analysis, patients with E-cadherin-positive tumors had significantly better 3-and 5-year survival rates than patients with E-cadherin-negative tumors. This prognostic impact remained present in a multivariate Cox regression analysis, including the prognostic parameters pT category, pN category and vascular invasion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682585     DOI: 10.1002/(SICI)1097-0215(19960621)69:3<184::AID-IJC6>3.0.CO;2-W

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

1.  Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.

Authors:  A O Chan; S K Lam; K M Chu; C M Lam; E Kwok; S Y Leung; S T Yuen; S Y Law; W M Hui; K C Lai; C Y Wong; H C Hu; C L Lai; J Wong
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer.

Authors:  Yasuto Uchikado; Hiroshi Okumura; Sumiya Ishigami; Tetsuro Setoyama; Masataka Matsumoto; Tetsuhiro Owaki; Yoshiaki Kita; Shoji Natsugoe
Journal:  Gastric Cancer       Date:  2011-01-28       Impact factor: 7.370

3.  Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas.

Authors:  N C Hunt; A G Douglas-Jones; B Jasani; J M Morgan; M Pignatelli
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

4.  Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody.

Authors:  K F Becker; E Kremmer; M Eulitz; I Becker; G Handschuh; C Schuhmacher; W Müller; H E Gabbert; A Ochiai; S Hirohashi; H Höfler
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 5.  Recent progress in histochemistry and cell biology: the state of the art 2005.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2005-11-11       Impact factor: 4.304

Review 6.  The histochemistry and cell biology vade mecum: a review of 2005-2006.

Authors:  Douglas J Taatjes; Christian Zuber; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2006-11-24       Impact factor: 4.304

Review 7.  E-cadherin in gastric cancer.

Authors:  Annie On On Chan
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

8.  Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

Authors:  Ke Yin; Qiande Liao; Hongbo He; Da Zhong
Journal:  Med Oncol       Date:  2012-07-31       Impact factor: 3.064

9.  Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Authors:  Edaise M Silva; Maria D Begnami; José Humberto T G Fregnani; Adriane G Pelosof; Claudia Zitron; André L Montagnini; Fernando Augusto Soares
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

10.  miR-200 enhances mouse breast cancer cell colonization to form distant metastases.

Authors:  Derek M Dykxhoorn; Yichao Wu; Huangming Xie; Fengyan Yu; Ashish Lal; Fabio Petrocca; Denis Martinvalet; Erwei Song; Bing Lim; Judy Lieberman
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.